161 related articles for article (PubMed ID: 21933682)
1. Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.
Zhen J; Ali S; Dutta AK; Reith ME
J Neurosci Methods; 2012 Jan; 203(1):19-27. PubMed ID: 21933682
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
Reith ME; Wang LC; Dutta AK
J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.
Kiyono Y; Sugita T; Ueda M; Kawashima H; Kanegawa N; Kuge Y; Fujibayashi Y; Saji H
Nucl Med Biol; 2008 Feb; 35(2):213-8. PubMed ID: 18312831
[TBL] [Abstract][Full Text] [Related]
4. In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex.
Meyers B; Kritzer MF
Neuroscience; 2009 Mar; 159(1):271-82. PubMed ID: 19138725
[TBL] [Abstract][Full Text] [Related]
5. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
Sucic S; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
[TBL] [Abstract][Full Text] [Related]
6. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter.
Jayanthi LD; Prasad PD; Ramamoorthy S; Mahesh VB; Leibach FH; Ganapathy V
Biochemistry; 1993 Nov; 32(45):12178-85. PubMed ID: 8218295
[TBL] [Abstract][Full Text] [Related]
7. The role of cysteines and histidins of the norepinephrine transporter.
Wenge B; Bönisch H
Neurochem Res; 2013 Jul; 38(7):1303-14. PubMed ID: 23525969
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
Mash DC; Ouyang Q; Qin Y; Pablo J
J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
[TBL] [Abstract][Full Text] [Related]
10. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
Tejani-Butt SM
J Pharmacol Exp Ther; 1992 Jan; 260(1):427-36. PubMed ID: 1731049
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine transporters in rat placenta labeled with [3H]nisoxetine.
Shearman LP; Meyer JS
J Pharmacol Exp Ther; 1998 Feb; 284(2):736-43. PubMed ID: 9454822
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
Zhu MY; Shamburger S; Li J; Ordway GA
J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
[TBL] [Abstract][Full Text] [Related]
13. Binding of cocaine-like radioligands to the dopamine transporter at 37 degrees C: effect of Na+ and substrates.
Wang LC; Cui XN; Chen N; Reith ME
J Neurosci Methods; 2003 Dec; 131(1-2):27-33. PubMed ID: 14659820
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
Paczkowski FA; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
[TBL] [Abstract][Full Text] [Related]
15. Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl)tropane.
Chen N; Sun L; Reith ME
J Neurochem; 2002 Jun; 81(6):1383-93. PubMed ID: 12068085
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.
Reith ME; Selmeci G
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):309-18. PubMed ID: 1620235
[TBL] [Abstract][Full Text] [Related]
17. Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.
Mason JN; Deecher DC; Richmond RL; Stack G; Mahaney PE; Trybulski E; Winneker RC; Blakely RD
J Pharmacol Exp Ther; 2007 Nov; 323(2):720-9. PubMed ID: 17673606
[TBL] [Abstract][Full Text] [Related]
18. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
19. 2'-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding.
Seale TW; Avor K; Singh S; Hall N; Chan HM; Basmadjian GP
Neuroreport; 1997 Nov; 8(16):3571-5. PubMed ID: 9427328
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the splicing variants of human norepinephrine transporter.
Kitayama S; Morita K; Dohi T
Neurosci Lett; 2001 Oct; 312(2):108-12. PubMed ID: 11595346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
